Comparison between Bubble CPAP and Ventilator-derived CPAP in Rabbits  by Huang, Wen-Chin et al.
©2008 Taiwan Pediatric Association
ORIGINAL ARTICLE
Pediatr Neonatol 2008;49(6):223−229
*Corresponding author. Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, 325 Section 2, 
Cheng-Kung Road, Neihu District, Taipei City 114, Taiwan.
E-mail: guitar@ndmctsh.edu.tw
Background: Continuous positive airway pressure (CPAP) is used in infants with respi-
ratory distress and apnea. Bubble CPAP (B-CPAP) and ventilator-derived CPAP (V-CPAP) 
are two of the most popular CPAP modes, and use different pressure sources. However, 
few studies have been performed to compare their differences and effectiveness. 
This study was to determine whether B-CPAP and V-CPAP would have different effects 
on vital signs and arterial blood gas analysis.
Methods: We performed a randomized crossover study to measure vital signs, including 
mean blood pressure (MBP), heart rate (HR), and respiratory rate (RR), in 12 ketamine-
anesthetized healthy rabbits receiving endotracheal intubation by tracheostomy 
with B-CPAP or V-CPAP. Arterial blood was also sampled and analyzed for PaO2, PaCO2, 
HCO3¯ and pH.
Results: We observed statistically significant decreases in RR, pH and PaO2 with cor-
responding incrases in PaCO2 and HCO3¯ during the V-CPAP; however, no significant 
changes from baseline were observed for B-CPAP. Neither modality resulted in sta-
tistically significant changes in MBP or HR. Both forms of CPAP altered vital signs and 
arterial blood gases in a similar manner. There was a trend towards a lower percentage 
of change from baseline in all variables in B-CPAP compared with V-CPAP.
Conclusions: Our results suggest that B-CPAP seems to be superior to V-CPAP in terms 
of its effect on arterial blood gases and vital signs. We speculate that B-CPAP could 
have certain protective effects that better preserve both arterial blood gases and 
vital signs when compared to V-CPAP. However, the results of this study still need to 
be tested by clinical study.
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1. Introduction
Continuous positive airway pressure (CPAP) was first 
used to support the breathing of neonates in the 
early 1970s.1 Neonatal applications of CPAP include 
the prevention of extubation failure2 and the apnea 
of prematurity,3 and offers an alternative to intu-
bation and ventilation in respiratory distress syn-
drome.4 There are several techniques for CPAP 
generation; however, little evidence exists dem-
onstrating the superiority of one technique over 
another.5−7
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For the past 30 years, CPAP has been primarily 
delivered to neonates using certain devices con-
nected to a conventional mechanical ventilator 
(ventilator-derived CPAP, V-CPAP). In V-CPAP, a variable 
resistance in a valve is adjusted to provide resis tance 
to the flow of air. Underwater bubble CPAP (B-CPAP) 
has provided an alternative to pressure derived from 
conventional ventilators and has remained in use since 
first devised in the early 1970s.1 The positive pressure 
in the circuit is achieved by simply immersing the 
distal expiratory tubing in a water column to a desired 
depth rather than using a variable resistor. Although 
these two different pressure sources for CPAP deliv-
ery have been used for three decades, surprisingly 
few studies have been performed to compare their 
differences and effectiveness.8,9
The objective of this study was to determine 
whether vital signs and arterial blood gas analyses 
were influenced by the application of CPAP in spon-
taneously breathing healthy rabbits, and if there 
were an impact, whether B-CPAP and V-CPAP would 
differ in this regard.
2. Materials and Methods
The experiments were approved by the local animal 
ethics committee of the National Defense Medical 
Center. Twelve pathogen-free, female, juvenile New 
Zealand White rabbits (mean body weight 1.86 ± 
0.22 kg) were used in this study.
2.1. Surgical preparation
Animals were anesthetized by means of an intramus-
cular injection of a mixture of ketamine (23 mg/kg), 
acepromazine (0.58 mg/kg), and xylazine (0.8 mg/kg). 
The left marginal ear vein was cannulated to admin-
ister a continuous infusion of 5% dextrose at a rate 
of 5 mL/kg/h, and a catheter was inserted in the 
right auricular artery to obtain samples for blood 
gas analysis. The animals were placed in the supine 
position and given a tracheotomy just below the 
cricoid cartilage. An endotracheal tube of 3.0 mm 
inner diameter was then inserted. The tracheal walls 
were tightened with 3−0 nylon suture around the 
endotracheal tube to avoid accidental extubation 
and leakage of air.
The endotracheal tube was connected to a ven-
tilator (Sechrist Infant Ventilator, model IV-100B, 
Sechrist Industries, Anaheim, CA, USA), and the rab-
bits were allowed to breathe spontaneously without 
assisted ventilation (ventilation rate = 0, FiO2 = 21%, 
flow = 8 L/min). The end of the exhalation hose was 
open to make the circuit at a CPAP of 0 cmH2O. 
A catheter primed with normal saline containing 
heparin was introduced into the left carotid artery 
for the continuous registration of arterial blood 
pressure and heart rate (PowerLab hardware, Chart 
version 4.2 software; AD Instruments, Castle Hill, 
Australia).
2.2. CPAP setup
CPAP was achieved by using two modes: V-CPAP and 
B-CPAP. The circuit structures for both modes were 
almost identical. The ventilator (Sechrist Industries) 
provided gas flow at a rate of 8 L/min. The only 
difference between the modes was the site to 
which the end of the exhalation hose connected. 
For V-CPAP, the hose was connected to the exhala-
tion valve of the ventilator. The pressure tube was 
connected to the Y-piece and the pressure was ad-
justed at 5 cmH2O. For B-CPAP, the hose was sub-
merged under 5 cm of water to obtain 5 cmH2O of 
CPAP (Figure 1).
2.3. Anesthesia maintenance
During the surgical preparation, anesthesia was main-
tained with repeated intravenous injections of keta-
mine (20 mg/kg). After instrumentation, the rabbits 
received another dose of ketamine to prevent them 
from awakening during the experiment. The injection 
of ketamine decreased the animals’ blood pressure 
and heart rate, though the measures returned to 
baseline, usually within 5 minutes. In all animals, we 
allowed a delay of at least 10 minutes after the 
injection of ketamine and before experimentation 
to obtain stable circulatory conditions.
2.4. Experimental protocol
In a crossover design, each rabbit received two courses 
(I, II) of the experimental procedure (Figure 2). Each 
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Figure 1 Schematic representation of the CPAP circuit. 
For V-CPAP, the exhalation hose was connected to the 
exhalation valve of the ventilator; for B-CPAP, the exha-
lation hose was submerged under 5 cm of water.
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course was comprised of two 6-minute periods. In the 
first period, which was a baseline period (BL-V in 
sequence A; BL-B in sequence B), the rabbits re-
ceived 0 cmH2O of CPAP by keeping the exhalation 
hose open. In the second period, the rabbits were 
randomly assigned to receive V-CPAP (sequence A) 
or B-CPAP (sequence B) by connecting the end of 
the exhalation hose to the exhalation valve of the 
ventilator or submerging it into water. Randomization 
was performed using a computer program that gen-
erated random numbers to determine the mode of 
CPAP to be first used.
After completing course I of the experiment, CPAP 
was returned to 0 cmH2O by disconnecting the exha-
lation hose from the ventilator (in sequence A) or 
pulling it out of the water (in sequence B). The rab-
bits then received another dose of ketamine, and 
a second course was performed at least 10 minutes 
later when the rabbits’ circulatory conditions were 
stable. In the first period of course II, the CPAP mode 
was still 0 cmH2O as a baseline (BL-B in sequence A; 
BL-V in sequence B). In the second period of course II, 
the CPAP mode was changed to the CPAP mode not 
used in the second period of course I.
2.5. Data collection
Vital signs data, including mean blood pressure (MBP), 
heart rate (HR) and respiratory rate (RR), were 
collected during the 2.5- to 4.5-minute timeframe 
of each period, and were used for statistical analysis. 
RR was measured by a manual count of chest move-
ments over this 120-second timeframe. The mean 
of each variable was used to represent the result 
for the period.
Arterial blood was sampled for blood gas analysis 
at 5 minutes into each period. Arterial blood samples 
were analyzed for PaO2, PaCO2, HCO3¯, and pH by a 
blood gas analyzer (ABL 510, Radiometer, Copenhagen, 
Denmark).
2.6. Statistical analysis
The Wilcoxon signed ranks test was used for com-
parisons of vital signs (MBP, HR and RR) and arterial 
blood gas (PaO2, PaCO2, HCO3¯ and pH) between 
periods (BL-V and V-CPAP, BL-B and B-CPAP, and BL-V 
and BL-B) and between the percentage change from 
baseline of each CPAP modality. To test for “carry-
over” and “period” effects, we used nonparametric 
Mann-Whitney tests (two-tailed) on the sums and 
the differences, respectively, of these variables 
for the V-CPAP and B-CPAP. Statistical analysis was 
performed using SPSS software for Windows, version 
11.0 (SPSS, Inc., Chicago, IL, USA). A p-value ≤ 0.05 
was considered statistically significant.
3. Results
In total, we performed 24 courses of experiments. 
Six rabbits were randomly assigned to receive se-
quence A, and six received sequence B. Accordingly, 
there were twelve V-CPAP periods and twelve B-CPAP 
periods in this study.
The effect of the two different modes of CPAP on 
vital signs (RR, MBP and HR) and arterial blood gas 
(PaO2, PaCO2, HCO3¯ and pH) are shown in Figures 3 
and 4. When we compared data from the two base-
line periods, we found no significant differences ex-
cept in MBP, which was significantly higher during 
BL-V than BL-B (p = 0.018). We observed statistically 
significant decreases in RR, pH and PaO2 with cor-
responding increases in PaCO2 and HCO3 during the 
V-CPAP; however, no significant changes from base-
line were observed for B-CPAP. Neither modality 
resulted in statistically significant changes in MBP 
or HR.
The mean percentage of change in variables from 
baseline of these two CPAP modalities is shown in 
Figure 5. Both forms of CPAP altered vital signs and 
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Figure 2 Study protocol. Each rabbit was randomly assigned to one of two sequences—A or B. BL = baseline period.
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Figure 4 Effect of modes of CPAP on arterial blood gas measures. Median values are indicated with horizontal lines.
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arterial blood gases in a similar manner. The changes 
tended to be higher in all of these variables during 
V-CPAP than B-CPAP, and the differences between 
these two CPAP modalities in mean percentage change 
from baseline in RR and MBP were significant (p = 0.023 
and 0.050, respectively). There were no significant 
carryover or period effects, except in MBP (carryover 
effect, p = 0.01).
4. Discussion
In this study, we demonstrated that V-CPAP and 
B-CPAP both affected vital signs and arterial blood 
gases in a similar manner in the healthy rabbit model. 
Moreover, a striking finding in our study was that 
B-CPAP had no significant effect on vital signs and 
arterial blood gases, but V-CPAP significantly influ-
enced both arterial blood gases and the respiratory 
rate. In addition, B-CPAP had a smaller percentage 
change from baseline than V-CPAP, although the dif-
ference between them was only significant in the 
respiratory rate and mean blood pressure. These 
findings suggest that B-CPAP is superior to V-CPAP in 
terms of its effect on arterial blood gases and vital 
signs.
B-CPAP, in addition to providing positive airway 
pressure, delivers mechanical oscillatory vibrations 
that are transmitted into the chest secondary to the 
non-uniform flow of gas bubbles across a downstream 
underwater seal. These vibrations simulate waveforms 
produced by high-frequency ventilation (HFV).8,10 
Accordingly, B-CPAP may possess the characteristics 
of CPAP and HFV at the same time, and this may 
make B-CPAP to different V-CPAP. Hemodynamics has 
been reported to be better preserved during HFV 
than during conventionally controlled mechanical 
ventilation.11,12 However, the effect of B-CPAP on 
circulation is, to our knowledge, untested. Whether 
or not our results were related to the bubble-
associated high-frequency oscillation needs further 
exploration.
In general, the application of CPAP improves gas 
exchange, increases PaO2 and decreases PaCO2 due 
to increases in functional residual capacity. However, 
surpassing optimum CPAP levels can result in a fall in 
tidal volume and a rise in dead space ventilation, 
leading to a rise in PaCO2. Furthermore, high CPAP 
levels can lead to a reduction in venous return, 
compromised cardiac output, increased pulmonary 
vascular resistance (PVR), and enhanced ventilation-
perfusion mismatch, resulting in a lower PaO2.13,14 
In addition, an increase in PVR results in a shift of the 
intraventricular septum to the left and inhibits left 
ventricular filling, further decreasing cardiac out-
put. In our study, the CPAP level we used (5 cmH2O) 
may have been too much for healthy rabbit lungs, 
resulting in a PaO2 decrease and a PaCO2 increase. 
Consequently, the cardiac output might have been 
reduced, producing an insignificantly mild increase in 
heart rate and a slight decrease in blood pressure.
The decreases in the respiratory rate during CPAP, 
both ventilator-derived (significant) and bubble (insig-
nificant), are not surprising and have been reported 
previously. CPAP can assist the respiratory muscles,15,16 
thereby reducing inspiratory work, as indicated by 
a decrease in the respiratory rate.17 Furthermore, it 
has been shown that both inspiratory and expiratory 
times are increased with CPAP,18,19 causing a decrease 
in the respiratory rate.
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Figure 5 Mean percentage change in variables from baseline of each CPAP modality. * = mean percentage change 
from baseline has reached significance.
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One of the primary goals in neonatal medicine 
today is to decrease pulmonary injury and avoid 
chronic lung disease (CLD) while preserving brain 
function. Studies have shown that the “Columbia 
approach”20,21 in which B-CPAP is used early in the 
course of respiratory distress in both premature and 
term-gestation infants, can effectively lower the 
incidence of CLD.22−24 At Columbia University, the 
early initiation of nasal prong B-CPAP in combination 
with a tolerance to elevated PCO2 levels has been 
shown to reduce the incidence of CLD to < 5% in 
infants weighing less than 1500 g.25
However, the mode of pressure generation for 
the delivery of nasal CPAP which most effectively 
reduces the need for additional respiratory support 
is still uncertain. It is an issue of significant clinical 
interest as to whether B-CPAP, as opposed to CPAP 
only is one of the keys to reducing the incidence of 
CLD. A comparison of underwater B-CPAP with V-CPAP 
in preterm neonates suggested that the bubbling 
contributed to gas exchange which decreases the 
infant’s required work of breathing.8 The results from 
that study also suggest that B-CPAP may decrease 
the need for tidal ventilation, resulting in decreased 
fatigue and a decreased need for endotracheal in-
tubation and positive pressure ventilation, which 
may help to reduce the incidence of CLD. Another 
study compared early B-CPAP with “conventional” 
(ventilator-derived) CPAP9 and showed that B-CPAP, 
but not conventional CPAP, reduced the use of post-
natal steroids and produced a directional, but insig-
nificant, decrease in the incidence of CLD. However, 
this was not a randomized study. Our study showed 
that B-CPAP had no significant adverse effects on 
vitals signs and arterial blood gases, but V-CPAP 
did, which suggests that B-CPAP might have certain 
protective effects that contribute to a lower inci-
dence of CLD. Further study is needed to investigate 
these ideas.
There is an important limitation in this study in 
that we did not measure the actual airway end-
distending pressure in either CPAP modality. Courtney 
et al26 showed that in three different nasal CPAP 
devices, there were no significant differences in the 
respiratory rate and the oxygen changes from baseline 
among the groups at CPAP of 8, 6, and 4 cmH2O. 
Coddazzi’s study27 also showed that CPAP increments 
(from 0 to 10 cmH2O) did not significantly alter PaCO2, 
respiratory rate, heart rate, or systolic blood pressure. 
Accordingly, we believe that the failure to demon-
strate equivalence between the two modalities with 
respect to the mean delivered distending pressure 
may be not so important. Moreover, in current clinical 
practice, the desired CPAP level is usually achieved 
just by placing the tubing in a water column to a 
specific depth in B-CPAP, or adjusting the pressure 
measured at the Y-piece in V-CPAP, and the actual 
airway end-distending pressure is usually not mea-
sured. We believed that reflecting the true clinical 
situation was more practical than measuring the 
actual airway end-distending pressure.
5. Conclusion
In conclusion, from our preliminary results, B-CPAP 
seems to be superior to V-CPAP in terms of its effect 
on arterial blood gases and vital signs. We speculate 
that B-CPAP could have certain protective effects 
that better preserve arterial blood gases and vital 
signs than V-CPAP. Because the lungs in the rabbits in 
our study functioned normally, further study is needed 
to assess the value of B-CPAP in the treatment of 
immature lungs or more compromised lung conditions; 
a larger number of subjects and a longer study du-
ration are also suggested. Since it is always difficult 
to extrapolate from findings in animal models to 
humans, the results of this study can only give an 
indication of what may occur in humans and results 
still need to be attained by a clinical study.
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